MR applies genetic variations associated with environmental exposures as instrumental variables (IVs) to assess associated exposures (e.g., telomere length) and outcomes (e.g., the prognosis of breast cancer with different status of ER) (32). Here, ESR1 is linked to breast carcinoma.